Gibanje cen prve ravni anatomsko-terapevtsko-kemične klasifikacije reguliranih zdravil
Price developments of the first level of anatomic-therapeutic-chemical classification of regulated medicines

slovenian

2013

volume 82, issue 9

classification   drug   medicines   prices   regulation   Slovenia

Slovensko zdravniško društvo
(Obvezni izvod spletne publikacije)

Background: This paper analyses the impact of price regulation at the first level of anatomic-therapeutic-chemical (ATC) classification of medicines in order to present their developments by medicines structure. Methods: The analysis included 760 regulated wholesale prices of medicines prescribed on outpatient prescription, which are partly or completely financed by public expenditures in the period 20032010. They are classified at the first level, i.e., anatomic main groups by ATC classification. The impact of price regulation on the patterns in wholesale price developments of medicines is estimated by the Lasyperes index and Wilcoxon signed rank test. Results: The Laspeyres index confirmed the reduction in regulated wholesale prices of medicines for the majority of anatomical main groups of medicines by ATC classification in the years 20032010. With some exceptions, this finding was also confirmed by statistically significant differences in the Wilcoxon signed rank test. Conclusions: Differences in the movement of wholesale prices of anatomic main groups of medicines by ATC classification are associated with the measures of price regulation for medicines and over time. The greatest reductions in prices of medicines are found for the anatomic main groups with a greater number of generic medicines and interchangeable medicines and vice versa, the least reductions or even increases are found for medicines with fewer generic medicines and limited or even nonexistent interchangeability

10.10.2014